"10.1371_journal.pone.0150733","plos one","2016-03-16T00:00:00Z","Bertrand Nalpas; Philippe Ichaï; Laure Jamot; Nicolas Carbonell; Marika Rudler; Philippe Mathurin; François Durand; Guido Gerken; Michael Manns; Christian Trautwein; Dominique Larrey; Sylvie Radenne; Christophe Duvoux; Vincent Leroy; Jacques Bernuau; Jamila Faivre; Nicolas Moniaux; Christian Bréchot; Gilles Amouyal; Paul Amouyal; Didier Samuel","Inserm, Département de l’Information Scientifique et de la Communication, Paris, France; Centre Hépatobiliaire Paul Brousse and Inserm U 1193, Villejuif, France; Hôpital Universitaire Paul Brousse, Villejuif, France; Alfact Innovation, Paris, France; Service Hépato-gastro-entérologie, Hôpital Saint Antoine, Paris, France; Service Hépatologie et de Gastroentérologie, Hôpital La Pitié Salpétrière, Paris, France; Service des maladies de l'appareil digestif, Hôpital Claude Huriez, Lille, France; Service Hépatologie, Hôpital Beaujon, Clichy, France; Gastroenterology and Hepatology Unit, University of Essen, Essen, Germany; Gastroenterology and Hepatology Unit, University of Hanover, Hanover, Germany; Medizinische Klinik III, University Clinic, RWTH-Aachen, Aachen, Germany; Service Hépato-Gastro-Entérologie, Hôpital Saint-Eloi, Montpellier, France; Service Hépatologie et Gastro-Entérologie, Hôpital Croix-Rousse, Lyon, France; Service d'Hépato-Gastro-Entérologie, Hôpital Henri MondorCréteil, France; Département d’Hépato-Gastroentérologie, Hôpital de Grenoble, Grenoble, France; Institut Pasteur, Paris, France","Conceived and designed the experiments: BN PI LJ JB CB GA PA DS. Performed the experiments: NC MR PM FD GG MM CT DL SR CD VL. Analyzed the data: BN PI LJ JF NM CB GA PA DS. Wrote the paper: BN.","Paul Amouyal is Chairman of Alfact Innovation. Gilles Amouyal is CEO of Alfact Innovation. Christian Brechot is scientific adviser and share-holder at Alfact Innovation. Bertrand Nalpas and Jamila Faivre are scientific consultant to Alfact Innovation. Laure Jamot was employed to manage and supervise the clinical trial. ALF-5755 patent belongs to Alfact innovation: (https://www.google.com/patents/US8329661). The funder provided support in the form of salaries for author [LJ] and honorarium for author [BN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2016","03","Bertrand Nalpas","BN",21,TRUE,8,11,9,1,TRUE,TRUE,FALSE,0,NA,FALSE
